In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses the potential clinical benefit of rechallenging with JAK inhibitor therapy in patients with myeloproliferative neoplasms (MPNs). Watch the interview.

Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.

Dr. Ruben Mesa, Mays Cancer Center Director, contributes to The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Read the story.

Darpan Patel, PhD, a faculty member in the School of Nursing, and Pratap Kumar, PhD, in the Department of Molecular Medicine, explain why cork tree bark, an herbal remedy that’s been around for centuries, is being studied as a way to shrink prostate tumors.